ASX:CP1

CannPal Animal Therapeutics (CP1) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free CP1 Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get CannPal Animal Therapeutics alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About CannPal Animal Therapeutics Stock (ASX:CP1)

CannPal Animal Therapeutics Limited, an animal health company, engages in the research and development of plant-based therapeutic products for pets in Australia. It develops CPAT-01, a cannabis-derived pharmaceutical product to provide veterinarians and pet owners to treat pain and inflammation in dogs. The company was incorporated in 2016 and is based in Double Bay, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

CP1 Stock News Headlines

October 12, 2023 | bbc.co.uk

How do animals grow?

October 2, 2023 | bbc.co.uk

Experimenting on animals

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

September 15, 2023 | newsweek.com

Weird Animals

September 11, 2023 | bbc.com

The animals that could be dreaming

September 4, 2023 | usatoday.com

From tarantulas to tigers, watch animals get on the scale for London Zoo's annual weigh-in

August 9, 2023 | bbc.co.uk

How animals reproduce

June 2, 2023 | fool.com

Elanco Animal Health (NYSE: ELAN)

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

May 21, 2023 | newsweek.com

Animal attacks

May 10, 2023 | usatoday.com

Stuffed animals are germ magnets—here's how to wash 'em

May 9, 2023 | bbc.co.uk

The ethics of speciesism

May 7, 2023 | usatoday.com

Are sharks fish? Learn where the top of the food chain ranks in the animal kingdom.

April 13, 2023 | npr.org

Talking Animals

March 21, 2023 | npr.org

Animals

March 17, 2023 | newsweek.com

Animal Abuse

February 24, 2023 | news.yahoo.com

'Forever chemicals' found in animals around the world

February 22, 2023 | nytimes.com

The Case for Sleeping With Stuffed Animals as an Adult

January 13, 2023 | foxnews.com

Nebraska man with 665 animals in home sentenced for animal cruelty

See More Headlines

Receive CP1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CannPal Animal Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: ASX:CP1
CUSIP: N/A
CIK: N/A
Web: www.cannpal.com
Phone: 61 2 6108 3622
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 16.22
Quick Ratio: 16.22

Sales & Book Value

Annual Sales: $802,623.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 3.38
Book Value: A$0.01 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 93,125,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Layton Patrick Mills
Founder, MD & Director
Dr. Margaret Curtis
Head of Clinical Devel. and R&D
Mr. Baden Maxwell Bowen
CFO & Company Sec.
Dr. Rayson Tan
Chief Scientific Officer & Member of Advisory Board

Key Competitors

View All Competitors

This page (ASX:CP1) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CannPal Animal Therapeutics (CP1) Stock Price, News & Analysis

About CannPal Animal Therapeutics Stock (ASX:CP1)

CP1 Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info